HHS Provides an Additional $250 Million to Help U.S. Health Care Systems Respond to COVID-19June 2, 2020
Allergan Aesthetics Launches Dedicated Multi-Channel Campaign to Contact Patients Who May Not Be Aware of The Biocell® RecallJune 2, 2020
Coronavirus (COVID-19) Update: FDA Takes Action to Protect Public Health; Increase Supply of Alcohol-Based Hand SanitizerJune 2, 2020
Amneal Pharmaceuticals LLC Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended Release Tablets, USP, 500 mg and 750 mg, Due to Detection of N-Nitrosodimethylamine (NDMA) ImpurityJune 1, 2020
Federal judge enters order of permanent injunction against New York company for distributing unapproved drugsJune 1, 2020
HHS Adds $628 Million to Contract with Emergent BioSolutions to Secure CDMO Manufacturing Capacity for Operation Warp SpeedJune 1, 2020
CHS Nutrition Recalls Champion Meat Goat Pellets R20, Medicated Feed, Because of Possible Rumensin (monensin) Health RiskMay 30, 2020
Coronavirus (COVID-19) Update: FDA Takes Steps to Streamline Development of Tests With At-Home Sample CollectionMay 29, 2020
FDA Approves New Option to Treat Heavy Menstrual Bleeding Associated with Fibroids in WomenMay 29, 2020
FDA Alerts Patients and Health Care Professionals to Nitrosamine Impurity Findings in Certain Metformin Extended-Release ProductsMay 29, 2020
Apotex Corp. Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets 500mg Due to the Detection of N-nitrosodimethylamine (NDMA)May 28, 2020
FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer’s DiseaseMay 28, 2020
